RecruitingNot ApplicableNCT07256119
Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Sponsor
Ain Shams University
Enrollment
40 participants
Start Date
Aug 6, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
the purpose of this study is to evaluate the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years
Plain Language Summary
Simplified for easier understanding
This study tests whether alpha lipoic acid — a naturally occurring antioxidant supplement — can reduce radiation-related skin damage (called radiation dermatitis) in women receiving radiotherapy for early-stage breast cancer.
**You may be eligible if...**
- You are a woman aged 18 or older
- You have been diagnosed with early-stage invasive breast cancer
- You are scheduled to receive adjuvant radiotherapy (40 Gy over 15 sessions)
**You may NOT be eligible if...**
- You have had radiotherapy before
- You have inflammatory breast cancer or metastatic (spread) breast cancer
- You have conditions that affect radiation skin response
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTAlpha Lipoic Acid
alpha lipoic acid 300 mg three times daily under the trade name of THIOTACID manufactured by EVAPHARMA.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07256119
Related Trials
The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities
NCT069220711 location
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
NCT075114911 location
Virtual Assistant for Exercise Adherence in Older ADULTS
NCT074985301 location
Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease
NCT068430051 location
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
NCT061985174 locations